DATAMEDS AI, INC.

NASDAQ: MEDS (DataMeds AI, Inc.)

Kemas kini terakhir: 4 hari lalu, 3:13AM

0.640

0.00 (-0.28%)

Penutupan Terdahulu 0.642
Jumlah Dagangan 551,574
Harga / Jualan (P/S) 0.240
Julat 52 Minggu
0.493 (-23%) — 33.15 (5077%)
Margin Keuntungan 52.46%
Margin Operasi (TTM) -153.67%
EPS Cair (TTM) -24.38
Jumlah Hutang/Ekuiti (D/E MRQ) 1.48%
Nisbah Semasa (MRQ) 4.75
Pulangan Atas Aset (ROA TTM) -71.92%
Pulangan Atas Ekuiti (ROE TTM) -269.31%

AISkor Stockmoo

-2.1
Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. info
Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info NA
Penilaian Relatif info NA
Pertumbuhan Tersirat info NA
Sejarah Penilaian info NA
Pulangan atas Modal info NA
Trend Perolehan info NA
Nilai Pegangan info NA
Premium Risiko info NA
Penilaian Pasaran info NA
Aliran menurun sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info
Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun. info
Daripada analisis teknikal AI kami terhadap carta. info NA
Corak Lilin info NA
Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info
Sentimen Pegangan info NA
Sentimen Berita info NA
Institusi bersih +0.66% daripada saham dalam pemfailan 13F terkini: 10 pemegang menambah, 4 mengurang (suku berakhir 30 Sep 2026). info
Kedudukan jual singkat +113.5% dari 31 Aug hingga 30 Oct 2026, 1 hari untuk tutup (FINRA). info
Aktiviti Orang Dalam info NA
Persekitaran pasaran berhati-hati. info
Sektor ketinggalan berbanding pasaran.
Tonggak-tonggak sependapat, jadi skor diperkukuh.
Di bawah garis aliran jangka sederhana. info
Harga rendah berbanding purata 52 minggunya. Turun dalam tempoh 5 tahun. info
Aliran turun bagi ketiga-tiga tempoh. Momentum jangka pendek menurun. info
Paras sokongan dan rintangan menaik. info
Skor Akhir -2.09
Tunjuk semua

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Pharmaceutical Retailers (US) Bercampur Bercampur
Pharmaceutical Retailers (Global) Bercampur Bercampur
Stok DataMeds AI, Inc. Bercampur Bercampur

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B Skor
MEDS - - - - -2.1
WBA 10 B 4.34% - 1.44 -2.0
PETS 19 M - - 1.18 -3.9
RDGT 853 K - - 0.020 -2.2
SCNX - - - 0.080 -1.6
HITI 199 M - - 2.95 -1.7

Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its products and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Superlatus, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc.

Sektor Healthcare
Industri Pharmaceutical Retailers
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 63.99%
% Dimiliki oleh Institusi 10.25%

Pemilikan

Nama Tarikh Syer Dipegang
Onedigital Investment Advisors Llc 30 Sep 2026 21,369

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Institusi

Pemilikan institusi: 1.62%

Kedudukan Pemegang Saham
Bertambah 10 49,514
Berkurang 4 23,584
Baharu 7 34,444
Dijual habis 1 20,532

Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.

Kedudukan Jual Singkat

Penyelesaian Saham Hari untuk tutup
30 Oct 2026 371,417 1.0
15 Oct 2026 476,294 1.0
30 Sep 2026 525,081 1.0
15 Sep 2026 430,628 1.0
31 Aug 2026 173,986 1.0
14 Aug 2026 164,850 1.0

Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.

2 Positif 0 Negatif 0 Neutral
Tarikh Jenis Butiran
05 Nov 2026 Yahoo Finance DataMeds AI Signs Preliminary Agreement With Florida Health Insurer for GLP-1 Patient Management App
DataMeds AI, Inc. (NASDAQ:MEDS) announced that it has entered into a non-binding memorandum of understanding (MOU) with a Florida-based health maintenance organization (HMO) to introduce its Health Lives Here mobile application to the insurer’s members, initially focusing on patients receiving…
02 Nov 2026 Yahoo Finance DataMEDS AI Secures Supply Agreement for Six Compounded Peptides Following FDA Advisory Committee Recommendations
DataMEDS AI, Inc. (NASDAQ:MEDS) has announced that its pharmacy subsidiary, Corexa Health, has entered into a commercial supply agreement covering bulk drug substances and active pharmaceutical ingredients (APIs) for six peptides, as the company prepares to expand its compounded prescription…
23 Oct 2026 Yahoo Finance DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
The aim of HLH CRP is to bring respiratory season best practices to community pharmacies and improve access to protein-based vaccines, diagnostics and therapeutics targeting respiratory infectious diseases as cold and flu season begins across the U. Corexa Pharmacy in Lakeland, Florida will be the…
20 Oct 2026 Yahoo Finance DataMeds Regains Compliance With NASDAQ Listing Standards
TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. In order to regain compliance with the Equity Rule, DataMEDS needed to have a minimum stockholders' equity of $2…
16 Oct 2026 Yahoo Finance DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
DataMeds AI, Inc. (NASDAQ:MEDS) has outlined plans to expand into the peptide compounding market through its pharmacy subsidiary, Corexa Health, following a proposed policy change by the U.
16 Oct 2026 Yahoo Finance DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide marketTAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company…
14 Oct 2026 Yahoo Finance DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Platform to be integrated into Health Lives Here app as a subscription offeringTAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure…
13 Oct 2026 Yahoo Finance DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL – DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS SI,” “DataMEDS,” or the “Company”), a…
13 Oct 2026 Yahoo Finance DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
DataMeds AI, Inc. (NASDAQ:MEDS) has announced cost-reduction measures, including cuts to corporate management positions, as the company redirects resources towards commercialising its ChemoFx diagnostic laboratory test for gynaecological cancers.
12 Oct 2026 Yahoo Finance DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
DataMeds AI’s Helomics subsidiary has received a Medicaid coverage determination under Humana’s policy, potentially expanding reimbursement access for its precision oncology test while supporting commercial growth. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) has secured a Medicaid coverage…
12 Oct 2026 Yahoo Finance DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policyTAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. Medical Coverage Policies were reviewed by Humana's Medicaid Coverage Policy Adoption (MCPA) Forum, which incorporated the ChemoFx Assay in its Coverage…
01 Oct 2026 Yahoo Finance DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%
Corexa Pharmacy’s preliminary September revenue increased more than 66% from July, supported by retail customer growth and the launch of Tollo Health products. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) said Corexa Pharmacy generated preliminary, unaudited September 2026 revenue of more than…
01 Oct 2026 Yahoo Finance DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launchesTAMPA, FL / ACCESS Newswire / October 1, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare…
28 Sep 2026 Yahoo Finance Axe Compute Just Sold Its Cancer Business to Become an AI Stock
Axe Compute stock has rallied over 650% in the past six months as investors increasingly value it as an AI infrastructure stock. The challenge is now delivering on that promise.
28 Sep 2026 Yahoo Finance DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy Services
DataMeds AI (NASDAQ:MEDS) and Tollo Health launched the Health Lives Here mobile application, combining GLP-1 telehealth, pharmacy services, nutritional products and health tracking as part of a planned broader healthcare network. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) and Tollo Health…
28 Sep 2026 Yahoo Finance DataMeds AI stock rises on health app launch
Investing.com -- DataMeds AI Inc (NASDAQ:MEDS) shares jumped 25% Monday following the launch of its Health Lives Here mobile application in partnership with Tollo Health.
28 Sep 2026 Yahoo Finance DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy ServicesTAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc. The companies intend to expand the target patient populations in the fourth quarter of…
25 Sep 2026 Yahoo Finance DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health DataTAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial…
Papar semua
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
19 Jul 2024 08 Jul 2024 24 Jul 2024 1.5 Tunai
25 Mar 2024 28 Feb 2024 22 Mar 2024 8 Tunai

Persediaan Teknikal Sederhana

Susunan aliran
Kecerunan
Kemasukan
Dagangan
Aliran menurun: harga di bawah purata bergeraknya, dan purata itu sedang menurun. Harga telah jatuh jauh di bawah purata itu. Dagangan lebih tinggi pada hari harga turun.
Rintangan terdekat: 0.740 – 0.933 · paras kukuh

AI Analisis Teknikal

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Risiko / Ganjaran
TP1:
TP2:

Kerugian hingga SL berbanding keuntungan hingga setiap sasaran, dari EP. Nisbah 2 atau lebih biasanya dicari.

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda